Last viewed: RETA


Prices are updated after-hours



nasdaq:RETA Reata Pharmaceuticals, Inc.

RETA | $28.04 | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (-1.5% 1m) (-74.8% 1y) (0.0% 2d) (0.0% 3d) (-2.4% 7d) (-100.0% volume)
http://www.reatapharma.com
Sec Filling | Patents | 220 employees

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.

add to today's watch list email alert is off




education  

Press-releases


SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Reata Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - RETA
Published: 2022-01-18 (Crawled : 01:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -2.44% H: 0.0% C: 0.0%

als era deadline
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Reata Pharmaceuticals, Inc. - RETA
Published: 2022-01-14 (Crawled : 05:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -1.17% H: 3.88% C: 3.38%

als ces deadline
Reata Pharmaceuticals SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reata Pharmaceuticals, Inc. - RETA
Published: 2022-01-13 (Crawled : 03:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 2.13% C: -1.85%

als ces 100 deadline
NVEI INVESTOR ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nuvei Corporation Investors with Losses to Inquire About Class Action Investigation - NVEI
Published: 2022-01-05 (Crawled : 19:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.18% H: 6.44% C: 4.21%

corporation
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 18, 2022 - RETA
Published: 2022-01-03 (Crawled : 21:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: 6.59% H: 9.34% C: 2.3%

als deadline
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Reata Pharmaceuticals, Inc. - RETA
Published: 2021-12-31 (Crawled : 05:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.83% H: 5.47% C: 0.8%

als ces deadline
REATA PHARMACEUTICALS, INC. (NASDAQ: RETA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Reata Pharmaceuticals, Inc. (NASDAQ: RETA)
Published: 2021-12-30 (Crawled : 01:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.83% H: 5.47% C: 0.8%
DM | $3.99 | twitter stocktwits trandingview |
| | O: -2.56% H: 3.24% C: 0.2%

als ces nasdaq
REATA PHARMACEUTICALS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Reata Pharmaceuticals, Inc. - RETA
Published: 2021-12-29 (Crawled : 01:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.66% H: 7.67% C: 3.69%

als ces deadline
RETA NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RETA
Published: 2021-12-29 (Crawled : 23:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology
| | O: -0.66% H: 7.67% C: 3.69%

als trust deadline
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - RETA
Published: 2021-12-24 (Crawled : 05:00) - prnewswire.com
RETA | $28.04 | twitter stocktwits trandingview |
Health Technology

als deadline
See all


Last 15 days Sec forms
File Id Form Date Direction Code Amount Transacted Owned Amount
0001567619-21-012075 4 2021-06-14 Buy A 690 690
0001567619-21-012075 4 2021-06-14 Buy A 5000 5000


Your Today's Watch List
Sign in to create a watchlist
Today's Insiders Buying

Yesterday's Insiders Buying